Literature DB >> 12355038

Benefits of late reperfusion in the treatment of acute myocardial infarction.

Kinji Ishikawa1.   

Abstract

Early reperfusion of the infarct-related coronary artery is very much effective to treat the patients with acute myocardial infraction. However, there are many clinical as well as experimental evidences supporting the efficacy of late reperfusion therapy. In this article, effects of late reperfusion on mortality, left ventricular function, left ventricular dilatation and remodeling, or electrical stability were summarized. Also, the possible mechanisms for benefits of late reperfusion were discussed and the special role of epicardial rim bring about those benefits was emphasized.

Entities:  

Mesh：

Year:  2002        PMID： 12355038     DOI： 10.1023/a:1020439309681

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


  59 in total

1.  Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy.

Authors:  J A Puma; M H Sketch; T D Thompson; R J Simes; D C Morris; H D White; E J Topol; R M Califf
Journal:  Am J Cardiol       Date:  1999-02-15       Impact factor: 2.778

Review 2.  Occluded infarct-related arteries and clinical events.

Authors:  M Lund; J K French; H D White
Journal:  Prog Cardiovasc Dis       Date:  2000 May-Jun       Impact factor: 8.194

3.  Myocardial salvage by reperfusion 12 hours after coronary ligation in dogs.

Authors:  A Kimura; K Ishikawa; I Ogawa
Journal:  Jpn Circ J       Date:  1998-04

4.  Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction.

Authors:  H D White; D B Cross; J M Elliott; R M Norris; T W Yee
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

5.  Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction: myocardial contrast echocardiographic study.

Authors:  T Asanuma; K Tanabe; K Ochiai; H Yoshitomi; K Nakamura; Y Murakami; K Sano; T Shimada; R Murakami; S Morioka; S Beppu
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

6.  Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR).

Authors:  R Zahn; R Schiele; S Schneider; A K Gitt; H Wienbergen; K Seidl; C Bossaller; G F Hauf; M Gottwik; E Altmann; W Rosahl; J Senges
Journal:  J Invasive Cardiol       Date:  2001-05       Impact factor: 2.022

Review 7.  Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models.

Authors:  K A Reimer; R S Vander Heide; V J Richard
Journal:  Am J Cardiol       Date:  1993-12-16       Impact factor: 2.778

8.  Comparative effects of early and late reperfusion of the infarct-related coronary artery and collateral circulation which develops after infarction on left ventricular size and function.

Authors:  A Igawa; M Fujita; K Yamanishi; M Inoko; K Miwa
Journal:  Jpn Circ J       Date:  1993-11

9.  Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size.

Authors:  A Hirayama; T Adachi; S Asada; M Mishima; S Nanto; H Kusuoka; K Yamamoto; Y Matsumura; M Hori; M Inoue
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

Review 10.  Time to thrombolytic treatment: factors affecting delay and their influence on outcome.

Authors:  W D Weaver
Journal:  J Am Coll Cardiol       Date:  1995-06       Impact factor: 24.094
View more
  2 in total

1.  Complete rupture of the posterior papillary muscle caused by late reperfusion for acute myocardial infarction.

Authors:  Keiji Kamohara; Masaru Yoshikai; Junichi Murayama
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-03

2.  Inhibition of lncRNA XIST Improves Myocardial I/R Injury by Targeting miR-133a through Inhibition of Autophagy and Regulation of SOCS2.

Authors:  Zhiqiang Li; Yaping Zhang; Nan Ding; Yudong Zhao; Zankai Ye; Lei Shen; Hanlu Yi; Yaobin Zhu
Journal:  Mol Ther Nucleic Acids       Date:  2019-10-11       Impact factor: 8.886
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.